Strait of Hormuz Temporary Closure Triggers Market Alerts
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 10 hours ago
0mins
Should l Buy LMT?
Source: Benzinga
- Military Drill Impact: Iran's announcement of the temporary closure of the Strait of Hormuz for live-fire drills, a rare display of military force during nuclear negotiations, has triggered immediate alerts for global shipping giants and U.S. defense contractors.
- Oil Price Fluctuations: The closure of a passage that handles 20% of the world's oil has led to Brent crude trading at approximately $67.63 per barrel and West Texas Intermediate near $62.40, with slight increases, yet the market remains uncertain.
- Diplomatic Paradox: Despite escalating military tensions, Iranian Foreign Minister expressed optimism at a U.N. disarmament conference, claiming a
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LMT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LMT
Wall Street analysts forecast LMT stock price to fall
12 Analyst Rating
4 Buy
7 Hold
1 Sell
Hold
Current: 649.580
Low
430.00
Averages
535.50
High
605.00
Current: 649.580
Low
430.00
Averages
535.50
High
605.00
About LMT
Lockheed Martin Corporation is a global aerospace and defense company. The Company is engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. Its segments include Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS) and Space. Aeronautics segment is engaged in the research, design, development, manufacture, integration, sustainment, support and upgrade of advanced military aircraft. MFC segment provides air and missile defense systems, manned and unmanned ground vehicles, energy management solutions, and others. RMS segment designs, manufactures, services and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, and others. Its Space segment is engaged in the research and design, development, engineering and production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Military Drill Impact: Iran's announcement of the temporary closure of the Strait of Hormuz for live-fire drills, a rare display of military force during nuclear negotiations, has triggered immediate alerts for global shipping giants and U.S. defense contractors.
- Oil Price Fluctuations: The closure of a passage that handles 20% of the world's oil has led to Brent crude trading at approximately $67.63 per barrel and West Texas Intermediate near $62.40, with slight increases, yet the market remains uncertain.
- Diplomatic Paradox: Despite escalating military tensions, Iranian Foreign Minister expressed optimism at a U.N. disarmament conference, claiming a
See More

- Investment Stake Reduction: Mubadala Investment Company has cut its share stake in Arm Holdings by 8.3%, reducing its ownership to 1.4 million shares.
- Sponsored Ads Impact: The reduction in stake is highlighted in a recent SEC filing, indicating potential implications for sponsored ads and investment strategies.
See More

- Investment Stake: Mubadala has cut its share stake in Adobe by 49.0%, reducing its holdings to 11,570 shares.
- Regulatory Filing: The reduction in shares was disclosed in a recent SEC filing.
See More

Investment Increase: Mubadala Investment Company has raised its stake in CVS Health Corporation by 17.3%.
Share Count: The new total of shares held by Mubadala in CVS Health is now 149,769 shares.
See More

Investment Increase: Mubadala Investment Company has raised its share stake in ILEAD Sciences by 30.4%.
New Share Count: Following the investment, Mubadala now holds a total of 100,178 shares in ILEAD Sciences.
See More

Investment Increase: Mubadala Investment Company has raised its share stake in Bristol-Myers Squibb by 41.3%.
New Share Count: The total number of shares held by Mubadala in Bristol-Myers Squibb now stands at 256,633 shares.
See More






